首页> 美国卫生研究院文献>AIMS Microbiology >Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review
【2h】

Methicillin-resistant Staphylococcus aureus (MRSA) and anti-MRSA activities of extracts of some medicinal plants: A brief review

机译:耐甲氧西林金黄色葡萄球菌(MRSA)和某些药用植物提取物的抗MRSA活性:简要综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increasing emergence of multidrug-resistant infection causing microorganisms has become a significant burden globally. Despite the efforts of pharmaceuticals in producing relatively new antimicrobial drugs, they have resulted in a high rate of mortality, disability and diseases across the world especially in developing countries. Supporting this claim was the report of the Centre for Disease Control and Prevention (CDC) who estimated that over 2 million illnesses and 23,000 deaths per year are attributable to antibiotic resistant pathogens in the United States. They include Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-intermediate Staphylococcus aureus (VISA), Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-resistant enterococci (VRE), Extended spectrum beta-lactamases (ESBLs) producing gram-negative bacilli, Multidrug-resistant Streptococcus pneumoniae (MDRSP), Carbapenem-resistant Enterobacteriaceae (CRE) and Multidrug-resistant Acinetobacter baumannii. For MRSA, resistance is as a result of Methicillin-sensitive S. aureus (MSSA) strains that have acquired Staphylococcal Cassette Chromosome mec (SCCmec) which carries mecA gene. The gene encodes the penicillin-binding protein (PBP2a) which confers resistance to all β-lactam antibiotics. Vancomycin was previously the widely preferred drug for the treatment of MRSA infections. It is no longer the case with the emergence of S. aureus strains with reduced vancomycin sensitivity limiting the conventional treatment options for MRSA infections to very scanty expensive drugs. Presently, many researchers have reported the antibacterial activity of many plant extracts on MRSA. Hence, these medicinal plants might be promising candidates for treatment of MRSA infections. This work is a brief review on Methicillin-resistant Staphylococcus aureus (MRSA) and the anti-MRSA activities of extracts of selected medicinal plants.
机译:在全球范围内,引起微生物多药耐药性感染的日益增加已成为重大负担。尽管药物在生产相对较新的抗微生物药物方面做出了努力,但它们已导致全世界尤其是发展中国家的高死亡率,致残率和疾病发生率。疾病控制和预防中心(CDC)的报告支持了这一说法,该中心估计在美国每年有超过200万种疾病和23,000例死亡归因于抗生素抗性病原体。它们包括耐甲氧西林的金黄色葡萄球菌(MRSA),耐万古霉素的金黄色葡萄球菌(VISA),耐万古霉素的金黄色葡萄球菌(VRSA),耐万古霉素的肠球菌(VRE),产生革兰氏阴性的广谱β-内酰胺酶(ESBLs) ,耐多药肺炎链球菌(MDRSP),耐碳青霉烯肠杆菌科(CRE)和耐多药鲍曼不动杆菌。对于MRSA,耐药性是由于获得了带有mecA基因的葡萄球菌盒式染色体mec(SCCmec)的对甲氧西林敏感的金黄色葡萄球菌(MSSA)菌株的结果。该基因编码赋予所有β-内酰胺抗生素耐药性的青霉素结合蛋白(PBP2a)。万古霉素以前是用于治疗MRSA感染的广泛首选药物。万古霉素敏感性降低的金黄色葡萄球菌菌株的出现不再是这种情况,将用于MRSA感染的常规治疗选择限制在非常昂贵的药物上。目前,许多研究人员已经报道了许多植物提取物对MRSA的抗菌活性。因此,这些药用植物可能是治疗MRSA感染的有前途的候选药物。这项工作是对耐甲氧西林金黄色葡萄球菌(MRSA)以及所选药用植物提取物的抗MRSA活性的简要概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号